SCHEMBL18009297

SCHEMBL18009297

CCOC(=O)/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)OCC)N(C(=O)c2ccccc2)C1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.40
▸ CACNA1A O00555 1/20 0.40
▸ CACNA2D1 P54289 1/20 0.40
▸ CACNB1 Q02641 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PIK3CD O00329 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MDM2 Q00987 2/20 0.37
▸ MDM4 O15151 1/20 0.37
▸ PTGS2 P35354 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NR1D1 P20393 1/20 0.36
▸ SIRT3 Q9NTG7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18009283 0.94 ALDH1A1 (0.40) CACNA1ACACNA2D1CACNB1ALDH1A1SMN1; SMN2
SCHEMBL18009294 0.83 MMP2 (0.46) MAPTALDH1A1SMN1; SMN2PIK3CDMEN1
SCHEMBL18007438 0.81 HCAR2 (0.38) MAPTCACNA1ACACNA2D1CACNB1ALDH1A1
SCHEMBL18009302 0.80 PIK3CD (0.44) SMN1; SMN2PIK3CD
SCHEMBL18009292 0.80 PIK3CD (0.41) MAPTALDH1A1SMN1; SMN2PIK3CDKMT2A
SCHEMBL18009300 0.79 PIK3CD (0.42) MAPTALDH1A1SMN1; SMN2PIK3CDMEN1
SCHEMBL18007448 0.78 MEN1 (0.38) MAPTALDH1A1SMN1; SMN2PIK3CDMEN1
SCHEMBL18009461 0.78 PIK3CD (0.40) MAPTALDH1A1SMN1; SMN2PIK3CDMEN1
SCHEMBL18007451 0.76 PIK3CD (0.39) MAPTALDH1A1SMN1; SMN2PIK3CDMEN1
SCHEMBL18009293 0.76 KDM4E (0.42) ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016127186-A1 FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE NGUYEN MARK QUANG (US) 2016-08-11 — — WO disclosed
Send feedback